JPAD-Journal of Prevention of Alzheimers Disease

Scope & Guideline

Empowering Knowledge to Combat Alzheimer's Disease

Introduction

Immerse yourself in the scholarly insights of JPAD-Journal of Prevention of Alzheimers Disease with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2274-5807
PublisherSPRINGER BASEL AG
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJPAD-J PREV ALZHEIM / JPAD-J. Prev. Alzheimers Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPICASSOPLATZ 4, BASEL 4052, SWITZERLAND

Aims and Scopes

The Journal of Prevention of Alzheimer's Disease (JPAD) is dedicated to advancing the understanding and prevention of Alzheimer's disease through comprehensive research that encompasses a range of biological, psychological, and social factors. The journal focuses on innovative methodologies and interdisciplinary approaches to address the complexities of Alzheimer's disease and cognitive decline.
  1. Prevention Strategies and Interventions:
    The journal emphasizes the development and evaluation of various prevention strategies aimed at delaying or preventing cognitive decline and Alzheimer's disease. This includes lifestyle modifications, dietary interventions, and community-based programs.
  2. Biomarkers and Diagnostic Tools:
    Research on biomarkers for early detection and diagnosis of Alzheimer's disease is a core focus. This includes studies on blood, imaging, and genetic biomarkers that can help identify individuals at risk and monitor disease progression.
  3. Cognitive Function Assessment:
    JPAD publishes studies that explore cognitive assessments and their relevance in clinical and community settings. This includes the validation of new cognitive tests and the use of digital tools to evaluate cognitive function.
  4. Health Equity and Access:
    The journal addresses disparities in Alzheimer's disease research and treatment, focusing on recruitment strategies for underrepresented populations in clinical trials and the role of social determinants of health.
  5. Innovative Therapeutic Approaches:
    Research into new therapeutic strategies, including pharmacological and non-pharmacological interventions, is a significant area of interest. This includes studies on the efficacy of new drugs, dietary supplements, and lifestyle changes.
  6. Longitudinal Studies and Cohort Analyses:
    JPAD often features longitudinal studies that track cognitive decline over time, providing insights into the progression of Alzheimer's disease and associated risk factors.
The Journal of Prevention of Alzheimer's Disease is witnessing a dynamic shift towards several emerging themes that reflect current trends in Alzheimer's research. These themes highlight innovative approaches and interdisciplinary research efforts.
  1. Digital Health Interventions:
    The use of digital technologies for cognitive assessments, monitoring, and interventions is rapidly gaining traction. Research exploring how mobile applications and online platforms can enhance cognitive health is increasingly prevalent.
  2. Personalized Medicine Approaches:
    There is a growing emphasis on personalized medicine in Alzheimer's research, with studies focusing on tailoring interventions based on individual genetic, lifestyle, and health profiles.
  3. Multidomain Lifestyle Interventions:
    Research on multidomain interventions that combine dietary, physical, and cognitive activities to prevent cognitive decline is on the rise, reflecting an integrated approach to Alzheimer's prevention.
  4. Community Engagement in Research:
    The journal is increasingly highlighting the importance of community engagement in Alzheimer's research, particularly in recruiting diverse populations for clinical trials and addressing health disparities.
  5. Neuroinflammation and Immune Response:
    Emerging research into the role of neuroinflammation and the immune response in Alzheimer's disease is gaining prominence, with studies investigating therapeutic strategies targeting these pathways.
  6. Social Determinants of Health:
    There is an increasing focus on how social determinants, such as socioeconomic status and access to care, impact cognitive health and the progression of Alzheimer's disease.

Declining or Waning

While the Journal of Prevention of Alzheimer's Disease continues to evolve, certain themes have shown a decline in prominence in recent publications. These waning scopes suggest a shift in research priorities and emerging areas of focus.
  1. Historical Epidemiological Studies:
    There has been a noticeable decrease in the publication of traditional epidemiological studies that solely focus on historical data without integrating contemporary methods or innovative approaches.
  2. Single-Factor Risk Assessments:
    Research solely emphasizing single-factor risk assessments for Alzheimer's disease is declining. The trend is moving towards multifactorial approaches that consider a combination of genetic, environmental, and lifestyle factors.
  3. Basic Science Research:
    Studies focused exclusively on basic biological mechanisms of Alzheimer's disease without practical implications for prevention or intervention are becoming less frequent, as the journal emphasizes translational research.
  4. Pharmacological Monotherapy Trials:
    There is a waning interest in studies that evaluate the effectiveness of pharmacological monotherapies for Alzheimer's treatment, as the focus shifts towards combination therapies and holistic approaches.

Similar Journals

Aktualnosci Neurologiczne

Bridging Research and Practice in Neurology
Publisher: MEDICAL COMMUNICATIONSISSN: 1641-9227Frequency: 4 issues/year

Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Exploring the complexities of geriatric psychiatry and neurology.
Publisher: SAGE PUBLICATIONS INCISSN: 0891-9887Frequency: 6 issues/year

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, published by SAGE PUBLICATIONS INC, is a premier academic journal dedicated to advancing the understanding of mental health issues and neurological disorders in the aging population. With an established presence since 1988, this journal stands out in the fields of Geriatrics, Gerontology, Neurology, and Psychiatry, currently positioned in the Q2 category based on 2023 metrics, reflecting its influence and academic rigor. The journal is indexed in major databases and is highly regarded for its contributions, as evidenced by its strong Scopus rankings. It serves as an essential resource for researchers, clinicians, and students, offering insightful articles that explore the complex interplay between aging, mental health, and neurological conditions. Although it does not provide open access, it continues to be a vital source of scholarly knowledge for those dedicated to enhancing the well-being of the elderly population.

Journal of Nutrition Health & Aging

Transforming lives with cutting-edge insights on nutrition and aging.
Publisher: ELSEVIER SCIENCE INCISSN: 1279-7707Frequency: 10 issues/year

Welcome to the Journal of Nutrition Health & Aging, a prestigious publication dedicated to advancing knowledge in the critical fields of nutrition, gerontology, and geriatrics. Published by Elsevier Science Inc, this journal boasts an impressive impact factor and is recognized in the top quartile (Q1) of multiple categories including Geriatrics and Gerontology, Medicine (miscellaneous), and Nutrition and Dietetics. Since its inception in 1997, it has served as a vital platform for researchers, practitioners, and students alike to disseminate innovative research and practical applications relevant to aging populations. With a Scopus rank placing it in the top 15% of its field, it underscores its commitment to high-quality and impactful scholarship. Although it is not an open access journal, its significant reach ensures that valuable insights will continue to inform best practices and policy decisions in health and nutrition. We invite you to explore and contribute to this vital conversation surrounding health and well-being in older adults.

American Journal of Alzheimers Disease and Other Dementias

Pioneering research in dementia care and treatment.
Publisher: SAGE PUBLICATIONS INCISSN: 1533-3175Frequency: 81 issues/year

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

Frontiers in Aging Neuroscience

Unlocking Insights into Cognitive Aging.
Publisher: FRONTIERS MEDIA SAISSN: 1663-4365Frequency: 1 issue/year

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

NORDIC JOURNAL OF PSYCHIATRY

Pioneering insights into mental health for Nordic populations.
Publisher: TAYLOR & FRANCIS LTDISSN: 0803-9488Frequency: 8 issues/year

NORDIC JOURNAL OF PSYCHIATRY is a pivotal publication in the field of psychiatry and mental health, dedicated to advancing knowledge and fostering dialogue among researchers, clinicians, and students. Published by Taylor & Francis Ltd, this esteemed journal, with an ISSN of 0803-9488 and E-ISSN 1502-4725, serves as a platform for innovative research and critical reviews that address crucial mental health issues affecting Nordic populations and beyond. Its impact is underscored by a notable Q2 ranking in the Psychiatry and Mental Health category for 2023, along with a respectable position within the Scopus ranking at #268 out of 567. The journal has been a reliable source of scientific inquiry since its inception in 1947, and it aims to facilitate significant advancements in the understanding and treatment of psychiatric disorders. By providing access to high-quality research without open access options, NORDIC JOURNAL OF PSYCHIATRY remains a must-read for those dedicated to progressing mental health science in a global context.

Dementia and Geriatric Cognitive Disorders Extra

Advancing knowledge in cognitive health and aging.
Publisher: KARGERISSN: Frequency: 3 issues/year

Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.

GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry

Exploring Innovations in Gerontopsychology
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 1662-9647Frequency: 4 issues/year

GeroPsych - The Journal of Gerontopsychology and Geriatric Psychiatry, published by HOGREFE AG, stands as an essential academic resource in the evolving fields of gerontology and geriatric psychiatry. With a commitment to advancing the understanding of psychological well-being in older adults, the journal provides a platform for high-quality research, discussion, and innovation that caters to researchers, practitioners, and students alike. Although currently not an open-access publication, GeroPsych ensures accessibility through various academic libraries and institutions, fostering a collaborative approach to the complexities of aging and mental health. Recognized within the Q3 category for Geriatrics and Gerontology, and with its impact reflected in Scopus rankings, this journal plays a pivotal role in informing best practices and shaping policies within the interdisciplinary landscape of geriatric care. Spanning research from 2010 to 2024, GeroPsych is positioned as a leading journal for those committed to improving the mental health and psychological resilience of the aging population.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Exploring the Depths of Aging Minds: Your Gateway to Geriatric Psychiatry
Publisher: ELSEVIER SCIENCE INCISSN: 1064-7481Frequency: 12 issues/year

American Journal of Geriatric Psychiatry, published by Elsevier Science Inc, stands as a leading journal in the fields of geriatrics and gerontology, as well as psychiatry and mental health, recognized with a Q1 ranking in both categories for 2023. With a robust ISSN of 1064-7481 and E-ISSN 1545-7214, this journal has been a vital resource since its inception in 1993, contributing to the academic discourse surrounding the mental health of older adults. The journal focuses on publishing high-quality research and reviews that address the complexities of psychiatric disorders in geriatric populations, making it essential reading for researchers, professionals, and students dedicated to enhancing the mental well-being of elderly individuals. Notably, it achieves impressive Scopus rankings, sitting at the 5th percentile in Geriatrics and Gerontology and 24th percentile in Psychiatry and Mental Health, underscoring its impact and relevance in the academic community. While it does not offer open access, the journal's comprehensive content is vital for those looking to stay informed on the latest advancements in geriatric psychiatry. For more information, readers can access it via Elsevier's educational platforms.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Shaping the future of Alzheimer’s care through rigorous research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0893-0341Frequency: 4 issues/year

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.